Matterhorn Biosciences
Description: Matterhorn Biosciences develops MR1-targeting cellular therapies to detect and kill cancer cells via T cell receptors, leveraging breakthrough discoveries.
Country: Switzerland
Based in: Basel
Founded: 2020
Funding Stage: Seed
Tags: ['Biopharma', 'Biotechnology', 'Life Science', 'Medical']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.